TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 28 filers reported holding TALIS BIOMEDICAL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $996,488 | +65286.4% | 2,235,783 | 0.0% | 0.07% | -36.1% |
| Q3 2022 | $1,524 | -16.1% | 2,235,783 | 0.0% | 0.11% | -23.4% |
| Q2 2022 | $1,816 | -42.4% | 2,235,783 | 0.0% | 0.14% | -29.5% |
| Q1 2022 | $3,152 | -49.9% | 2,235,783 | +42.5% | 0.20% | -44.4% |
| Q4 2021 | $6,293 | – | 1,569,300 | – | 0.36% | – |
Download | ||||||